These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 34687015)

  • 21. Profiling of IgG N-glycome during mouse aging: Fucosylated diantennary glycans containing one Neu5Gc-linked LacNAc are associated with age.
    Han J; Pan Y; Gu Y; Xu X; Zhao R; Sha J; Zhang R; Gu J; Ren S
    J Proteomics; 2020 Oct; 229():103966. PubMed ID: 32891889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of N-Glycan Release from Human Immunoglobulin G (IgG) by PNGase F: All Glycans Are Not Created Equal.
    Huang Y; Orlando R
    J Biomol Tech; 2017 Dec; 28(4):150-157. PubMed ID: 29042829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgG Glyco-Engineering to Improve IVIg Potency.
    Bruggeman CW; Dekkers G; Visser R; Goes NWM; van den Berg TK; Rispens T; Vidarsson G; Kuijpers TW
    Front Immunol; 2018; 9():2442. PubMed ID: 30405631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycosylation of immunoglobin G in tumors: Function, regulation and clinical implications.
    Yang S; Cui M; Liu Q; Liao Q
    Cancer Lett; 2022 Nov; 549():215902. PubMed ID: 36096412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans.
    Dekkers G; Plomp R; Koeleman CA; Visser R; von Horsten HH; Sandig V; Rispens T; Wuhrer M; Vidarsson G
    Sci Rep; 2016 Nov; 6():36964. PubMed ID: 27872474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycosylation of random IgG distinguishes seropositive and seronegative rheumatoid arthritis.
    Magorivska I; Döncző B; Dumych T; Karmash A; Boichuk M; Hychka K; Mihalj M; Szabó M; Csánky E; Rech J; Guttman A; Vari SG; Bilyy R
    Autoimmunity; 2018 May; 51(3):111-117. PubMed ID: 29733234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis.
    Costa J; Streich L; Pinto S; Pronto-Laborinho A; Nimtz M; Conradt HS; de Carvalho M
    Mol Neurobiol; 2019 Aug; 56(8):5729-5739. PubMed ID: 30674035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of sialic acid linkage on antibody-fragment crystallizable receptor binding and antibody dependent cytotoxicity depend on levels of fucosylation/bisecting.
    Thomann M; Malik S; Kuhne F; Avenal C; Plath F; Bonnington L; Reusch D; Bulau P; Cymer F
    Bioanalysis; 2019 Aug; 11(15):1437-1449. PubMed ID: 31490109
    [No Abstract]   [Full Text] [Related]  

  • 29. An atomistic perspective on antibody-dependent cellular cytotoxicity quenching by core-fucosylation of IgG1 Fc N-glycans from enhanced sampling molecular dynamics.
    Harbison A; Fadda E
    Glycobiology; 2020 May; 30(6):407-414. PubMed ID: 31829411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of stage-dependent glycans on the Fc domains of IgG antibodies of ALS animals.
    Edri-Brami M; Sharoni H; Hayoun D; Skutelsky L; Nemirovsky A; Porgador A; Lichtenstein RG
    Exp Neurol; 2015 May; 267():95-106. PubMed ID: 25725350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
    Hills AE; Patel A; Boyd P; James DC
    Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival.
    Kodar K; Stadlmann J; Klaamas K; Sergeyev B; Kurtenkov O
    Glycoconj J; 2012 Jan; 29(1):57-66. PubMed ID: 22179780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Core Fucose on an IgG Antibody is an Endogenous Ligand of Dectin-1.
    Manabe Y; Marchetti R; Takakura Y; Nagasaki M; Nihei W; Takebe T; Tanaka K; Kabayama K; Chiodo F; Hanashima S; Kamada Y; Miyoshi E; Dulal HP; Yamaguchi Y; Adachi Y; Ohno N; Tanaka H; Silipo A; Fukase K; Molinaro A
    Angew Chem Int Ed Engl; 2019 Dec; 58(51):18697-18702. PubMed ID: 31625659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substitutions in the N-glycan core as regulators of biorecognition: the case of core-fucose and bisecting GlcNAc moieties.
    André S; Kozár T; Schuberth R; Unverzagt C; Kojima S; Gabius HJ
    Biochemistry; 2007 Jun; 46(23):6984-95. PubMed ID: 17497937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation between isomeric triantennary N-linked glycans by negative ion tandem mass spectrometry and confirmation of glycans containing galactose attached to the bisecting (beta1-4-GlcNAc) residue in N-glycans from IgG.
    Harvey DJ; Crispin M; Scanlan C; Singer BB; Lucka L; Chang VT; Radcliffe CM; Thobhani S; Yuen CT; Rudd PM
    Rapid Commun Mass Spectrom; 2008 Apr; 22(7):1047-52. PubMed ID: 18327885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific Sialoforms Required for the Immune Suppressive Activity of Human Soluble CD52.
    Shathili AM; Bandala-Sanchez E; John A; Goddard-Borger ED; Thaysen-Andersen M; Everest-Dass AV; Adams TE; Harrison LC; Packer NH
    Front Immunol; 2019; 10():1967. PubMed ID: 31507595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fc glycan-modulated immunoglobulin G effector functions.
    Quast I; Lünemann JD
    J Clin Immunol; 2014 Jul; 34 Suppl 1():S51-5. PubMed ID: 24760108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis.
    Zhou X; Kailemia MJ; Sun Y; Shuai Z; Yang GX; Dhaliwal S; Cristoferi L; Leung PSC; Invernizzi P; Bowlus CL; Lebrilla CB; Ansari AA; Ridgway WM; Zhang W; Gershwin ME
    J Autoimmun; 2020 Sep; 113():102503. PubMed ID: 32546343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interplay of protein engineering and glycoengineering to fine-tune antibody glycosylation and its impact on effector functions.
    Wang Q; Wang T; Zhang R; Yang S; McFarland KS; Chung CY; Jia H; Wang LX; Cipollo JF; Betenbaugh MJ
    Biotechnol Bioeng; 2022 Jan; 119(1):102-117. PubMed ID: 34647616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokines in the Immune Microenvironment Change the Glycosylation of IgG by Regulating Intracellular Glycosyltransferases.
    Cao Y; Song Z; Guo Z; Zhao X; Gong Y; Zhao K; Qu C; Huang Y; Li Y; Gao Y; Zhang J; Guo X
    Front Immunol; 2021; 12():724379. PubMed ID: 35140700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.